Articles

NCH also recertified by HITRUST® for patient privacy and data security protection.

Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.

Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.

Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers

Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.

The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.

Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols

Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.

Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.

As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.

Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.

New Century Health’s clinical pathways are rigorously developed and maintained by company clinicians under the oversight of an independent Scientific Advisory Board. Take a glimpse inside the board.

Oncology drug spending in the U.S. is on an unsustainable trajectory. Explore four paths to curb costs without compromising care.

Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.

Learn how CMS aims to increase risk, cash flow and predictability for practices while reducing administrative burdens, through its next model for value-based oncology care.